Impact of SGLT2 Inhibitors on Chronic Peritoneal Dialysis Patients.
NCT07491042
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
38
Enrollment
OTHER_GOV
Sponsor class
Conditions
End Stage Chronic Renal Failure
Interventions
DRUG:
Dapagliflozin
Sponsor
Oman Ministry of Health